The Vaccine Group (TVG; a 17% holding for Frontier IP) has announced positive progress for its novel animal Covid-19 vaccines. Two vaccine candidates of the four in development are now progressing after just eight weeks into animal testing after demonstrating in vitro expression of antigens belonging to the SARS-CoV-2 virus. Additionally, TVG also disclosed it is exploring the potential use of its vaccines in humans in an intriguing development for pan-species vaccinations. Even if the curren
23 Jun 2020
Progress of The Vaccine Group’s Covid-19 animal vaccines
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Progress of The Vaccine Group’s Covid-19 animal vaccines
Frontier IP Group Plc (FIPP:LON) | 38.5 0 0.0% | Mkt Cap: 21.6m
- Published:
23 Jun 2020 -
Author:
Edward Thomason -
Pages:
3
The Vaccine Group (TVG; a 17% holding for Frontier IP) has announced positive progress for its novel animal Covid-19 vaccines. Two vaccine candidates of the four in development are now progressing after just eight weeks into animal testing after demonstrating in vitro expression of antigens belonging to the SARS-CoV-2 virus. Additionally, TVG also disclosed it is exploring the potential use of its vaccines in humans in an intriguing development for pan-species vaccinations. Even if the curren